1. Serum Resistin Levels and Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- Author
-
Hiroaki Taniguchi, Nobukiyo Tanaka, Harumi Uto-Kondo, Haruo Nakamura, Ryuichi Kato, Fumitaka Ohsuzu, Yukihiko Momiyama, Koh Arakawa, and Reiko Ohmori
- Subjects
Male ,medicine.medical_specialty ,medicine.medical_treatment ,Coronary Artery Disease ,Kaplan-Meier Estimate ,Coronary Restenosis ,Coronary artery disease ,Restenosis ,Risk Factors ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Resistin ,cardiovascular diseases ,Angioplasty, Balloon, Coronary ,Aged ,Unstable angina ,business.industry ,Biochemistry (medical) ,Percutaneous coronary intervention ,Middle Aged ,medicine.disease ,Stenosis ,C-Reactive Protein ,Cardiovascular Diseases ,Multivariate Analysis ,Conventional PCI ,Cardiology ,Female ,Stents ,Cardiology and Cardiovascular Medicine ,business ,Mace ,Follow-Up Studies - Abstract
Resistin is an adipocytokine that may link inflammation and atherosclerosis.We studied the associations of resistin levels with cardiovascular events and restenosis.We measured pre-procedural serum resistin levels in 140 patients with coronary artery disease undergoing elective percutaneous coronary intervention (PCI), of whom 97 had a stent. Restenosis was defined as50% stenosis at follow-up angiography. Patients were followed for 3 years for major adverse cardiovascular events (MACE).At 8±6 months after PCI, reangiography was performed in 94 (67%) patients, of whom 42 had restenosis. Between 42 patients with restenosis and 52 without restenosis, resistin (4.5±2.6 vs. 4.5±2.5 ng/mL) and Creactive protein (CRP) (median 0.70 vs. 0.70 mg/L) levels did not differ. During 3-year follow-up, MACE occurred in 24 patients (1 death, 21 unstable angina, 2 stroke). Compared with 116 patients without MACE, 24 with MACE had higher resistin (5.4±2.4 vs. 4.3±2.5 ng/mL) and CRP (1.30 vs. 0.60 mg/L) levels (p0.05). Patients with MACE more often had resistin4.0 ng/mL than without MACE (75% vs. 35%, p0.001). Resistin correlated with CRP levels (r= 0.31). To clarify the association between MACE and resistin, patients were divided into 2 groups by resistin levels. Kaplan-Meier analysis showed a lower event-free survival rate in patients with resistin4.0 ng/mL than without it (p0.001). On multivariate analysis, resistin, but not CRP, was an independent predictor of MACE. The hazard ratio for MACE was 3.6 (95%CI=1.4-9.2) for resistin4.0 ng/mL.Serum resistin levels were found to be associated with further cardiovascular events in patients undergoing PCI.
- Published
- 2011